171 related articles for article (PubMed ID: 12886760)
1. Rat models of the metabolic syndrome.
Tofovic SP; Jackson EK
Methods Mol Med; 2003; 86():29-46. PubMed ID: 12886760
[No Abstract] [Full Text] [Related]
2. Experimental rat models to study the metabolic syndrome.
Aleixandre de Artiñano A; Miguel Castro M
Br J Nutr; 2009 Nov; 102(9):1246-53. PubMed ID: 19631025
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular remodeling and metabolic abnormalities in SHRSP.Z-Lepr(fa)/IzmDmcr rats as a new model of metabolic syndrome.
Ueno T; Takagi H; Fukuda N; Takahashi A; Yao EH; Mitsumata M; Hiraoka-Yamamoto J; Ikeda K; Matsumoto K; Yamori Y
Hypertens Res; 2008 May; 31(5):1021-31. PubMed ID: 18712058
[TBL] [Abstract][Full Text] [Related]
4. [Development of animal models for the metabolic syndrome with hypertension].
Fukuda N
Nihon Rinsho; 2006 Jul; 64 Suppl 5():300-2. PubMed ID: 16895197
[No Abstract] [Full Text] [Related]
5. Mechanisms of insulin resistance in hypertensive rats.
Shimamoto K; Ura N
Clin Exp Hypertens; 2006 Aug; 28(6):543-52. PubMed ID: 16893759
[TBL] [Abstract][Full Text] [Related]
6. The metabolic syndrome and chronic kidney disease.
Peralta CA; Kurella M; Lo JC; Chertow GM
Curr Opin Nephrol Hypertens; 2006 Jul; 15(4):361-5. PubMed ID: 16775449
[TBL] [Abstract][Full Text] [Related]
7. Obesity; epiphenomenon or cause of metabolic syndrome?
Lois K; Young J; Kumar S
Int J Clin Pract; 2008 Jun; 62(6):932-8. PubMed ID: 18479286
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of vasorelaxation responses in a rat model of metabolic syndrome.
Kagota S; Tanaka N; Kubota Y; Yamaguchi Y; Nakamura K; Kunitomo M; Shinozuka K
Clin Exp Pharmacol Physiol; 2004 Dec; 31 Suppl 2():S54-6. PubMed ID: 15649291
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance: the clinical spectrum.
Mantzoros CS; Flier JS
Adv Endocrinol Metab; 1995; 6():193-232. PubMed ID: 7671097
[No Abstract] [Full Text] [Related]
10. Molecular mechanisms of insulin resistance and associated diseases.
Mlinar B; Marc J; Janez A; Pfeifer M
Clin Chim Acta; 2007 Jan; 375(1-2):20-35. PubMed ID: 16956601
[TBL] [Abstract][Full Text] [Related]
11. Obesity and the metabolic syndrome.
Vega GL
Minerva Endocrinol; 2004 Jun; 29(2):47-54. PubMed ID: 15257255
[TBL] [Abstract][Full Text] [Related]
12. Role of stress in the pathogenesis of the metabolic syndrome.
Rosmond R
Psychoneuroendocrinology; 2005 Jan; 30(1):1-10. PubMed ID: 15358437
[TBL] [Abstract][Full Text] [Related]
13. Treatment of metabolic syndrome.
Wagh A; Stone NJ
Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):213-28. PubMed ID: 15151470
[TBL] [Abstract][Full Text] [Related]
14. Myocardial ischemic-reperfusion injury in a rat model of metabolic syndrome.
Mozaffari MS; Schaffer SW
Obesity (Silver Spring); 2008 Oct; 16(10):2253-8. PubMed ID: 18719642
[TBL] [Abstract][Full Text] [Related]
15. Food restriction improves glucose and lipid metabolism through Sirt1 expression: a study using a new rat model with obesity and severe hypertension.
Takemori K; Kimura T; Shirasaka N; Inoue T; Masuno K; Ito H
Life Sci; 2011 Jun; 88(25-26):1088-94. PubMed ID: 21514307
[TBL] [Abstract][Full Text] [Related]
16. Metabolic syndrome: comparison of the two commonly used animal models.
Oron-Herman M; Kamari Y; Grossman E; Yeger G; Peleg E; Shabtay Z; Shamiss A; Sharabi Y
Am J Hypertens; 2008 Sep; 21(9):1018-22. PubMed ID: 18566592
[TBL] [Abstract][Full Text] [Related]
17. Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models.
den Boer M; Voshol PJ; Kuipers F; Havekes LM; Romijn JA
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):644-9. PubMed ID: 14715643
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms by which poor early growth programs type-2 diabetes, obesity and the metabolic syndrome.
Fernandez-Twinn DS; Ozanne SE
Physiol Behav; 2006 Jun; 88(3):234-43. PubMed ID: 16782139
[TBL] [Abstract][Full Text] [Related]
19. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy.
Chapman MJ; Sposito AC
Pharmacol Ther; 2008 Mar; 117(3):354-73. PubMed ID: 18215759
[TBL] [Abstract][Full Text] [Related]
20. Familiality of metabolic abnormalities is dependent on age at onset and phenotype of the type 2 diabetic proband.
Tripathy D; Lindholm E; Isomaa B; Saloranta C; Tuomi T; Groop L
Am J Physiol Endocrinol Metab; 2003 Dec; 285(6):E1297-303. PubMed ID: 12954593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
